Skip to content
Dx

HCPCS Level II · Medical services and quality measures

M1238Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)

✓ Active

Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.

About M1238

M1238 is an HCPCS Level II code in the M series (medical services and quality measures), describing documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31).

It was added to HCPCS effective 01/01/2024.

Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.

Details

Short description
Doc 2nd recom hzv 2-6 mo int
Date added
01/01/2024
Action effective
01/01/2024
BETOS
Z2

Related M12xx codes

Common questions about M1238

Is HCPCS M1238 still valid?

Yes. M1238 is active in the CMS October 2026 HCPCS file.

Does Medicare cover M1238?

Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.